Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Regeneron Pharmaceuticals
Pharma
FDA denies Regeneron's bid for dosage flexibility on Eylea
The FDA has denied Regeneron's bid to stretch the administration of high-dose Eylea from a maximum frequency of every 16 weeks to every 24 weeks.
Kevin Dunleavy
Apr 21, 2025 8:45am
FDA approves Sanofi, Regeneron’s Dupixent for hives disorder
Apr 18, 2025 11:47am
Trump's tariffs, Leqembi, Kyowa Kirin—Fierce Pharma Asia
Apr 18, 2025 9:25am
Big Pharma celebrates International Women’s Day 2025
Mar 10, 2025 10:50am
Amgen, AZ Tezspire sinusitis data invite 'best-in-disease' talk
Mar 3, 2025 11:52am
BMS’ Opdualag flunks trial as adjuvant for resected melanoma
Feb 14, 2025 8:15am
